Bacterial Bloodstream Infections in HIV-infected Adults Attending a Lagos Teaching Hospital by Adeyemi, Adeleye I. et al.
©INTERNATIONAL CENTRE FOR DIARRHOEAL
DISEASE RESEARCH, BANGLADESH
J HEALTH POPUL NUTR  2010 Aug;28(4):318-326
ISSN 1606-0997 | $ 5.00+0.20
Bacterial Bloodstream Infections in HIV-infected 
Adults Attending a Lagos Teaching Hospital
Adeleye I.  Adeyemi1,  Akanmu A. Sulaiman2, Bamiro B. Solomon3, Obosi A. Chinedu1, and Inem A. Victor4
1Department of Microbiology, Faculty of Science, University of Lagos,  Akoka, Nigeria, 2Department of Haematology and Blood Transfusion, 
Lagos University Teaching Hospital, Idi-Araba, Nigeria, 3Department of Obstetrics and Gynaecology, Bacteriology Research Laboratory, 
College of Medicine, University of Lagos, Lagos, Nigeria, and 4Institute of Child Health and Primary Care,  
Lagos University Teaching Hospital, Idi-Araba, Nigeria
ABSTRACT
An investigation was carried out during October 2005–September 2006 to determine the prevalence of 
bloodstream infections in patients attending the outpatient department of the HIV/AIDS clinic at the Lagos 
University Teaching Hospital in Nigeria. Two hundred and one patients—86 males and 115 females—aged 
14-65 years were recruited for the study. Serological diagnosis was carried out on them to confirm their HIV 
status. Their CD4 counts were done using the micromagnetic bead method. Twenty mL of venous blood 
sample collected from each patient was inoculated into a pair of Oxoid Signal blood culture bottles for 2-14 
days. Thereafter, 0.1 mL of the sample was plated in duplicates on MacConkey, blood and chocolate agar 
media and incubated at 37 °C for 18-24 hours. The CD4+ counts were generally low as 67% of 140 patients 
sampled had <200 cells/µL of blood. Twenty-six bacterial isolates were obtained from the blood samples 
and comprised 15 (58%) coagulase-negative staphylococci as follows: Staphylococcus epidermidis (7), S. cohnii 
cohnii (1), S. cohnii urealyticum (2), S. chromogenes (1), S. warneri (2), S. scuri (1), and S. xylosus (1). Others were 
6 (23%) Gram-negative non-typhoid Salmonella spp., S. Typhimurium (4), S. Enteritidis (2); Pseudomonas 
fluorescens (1), Escherichia coli (1), Ochrobactrum anthropi (1), Moraxella sp. (1), and Chryseobacterium menin-
gosepticum. Results of antimicrobial susceptibility tests showed that coagulase-negative staphylococci had 
good sensitivities to vancomycin and most other antibiotics screened but were resistant mainly to ampi-
cilin and tetracycline. The Gram-negative organisms isolated also showed resistance to ampicillin, tetracy-
cline, chloramphenicol, and septrin. This study demonstrates that co-agulase-negative staphylococci and 
non-typhoidal Salmonellae are the most common aetiological agents of bacteraemia among HIV-infected 
adults attending the Lagos University Teaching Hospital, Nigeria. The organisms were resistant to older-
generation antibiotics often prescribed in this environment but were sensitive to vancomycin, cefotaxime, 
cefuroxime, and other new-generation antibiotics.
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INTRODUCTION
Nigeria has the highest population in Africa, with 1 
in 6 Africans being a Nigerian. The rate of HIV/ 
AIDS prevalence has grown slowly from 1.9% in 
1993 to 5.4% in 2003, and by the end of 2004, it 
was approaching 6% (1). However, a recent survey 
showed a decline to 4.6%, although the rate var-
ies from state to state, with some recording as high 
as 10.6% (Benue state) and as low as 1.0% (Ekiti 
state) (2). The clinical manifestation of HIV sec-
ondary infections in developing countries, includ-
ing Nigeria, shows a high prevalence of infections 
of the skin, gut, respiratory tract, tuberculosis, and 
malnutrition (3,4). The virus has a specific capacity 
to infect the CD4+ class of T lymphocyte, resulting 
in progressive decline in their (CD4+) number (5). 
This has serious health consequences since CD4+ 
cells constitute about 10% of the total T cell-pool. 
In AIDS patients, the number of CD4+ cells steadily 
decreases, and by the time opportunistic infections 
set in, CD4+ cells may be almost absent. These 
infections include spirochetal, protozoan, viral, 
fungal, mycobacterial and pyogenic bacterial infec-
tions (6). The later includes gastrointestinal diseases Adeyemi AI et al. Bacterial bloodstream infections in HIV-infected patients
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caused by enteric bacterial pathogens characterized 
by high rates of bacteraemia and frequent occur-
rence of diarrhoea. 
Disseminated infections with Salmonella Typhi- 
murium, S. Enteritidis, S. Arizona, S. Dublin, and   
other non-typhoidal Salmonella serotypes were reco- 
gnized early in the HIV epidemic (7). Similarly, 
encapsulated bacteria, including Streptococcus pneu-
moniae and Haemophilus influenzae are two of the 
most common bacterial pathogens in HIV-infected 
persons (8). Pseudomonas aeruginosa has emerged 
as one of the most common causes of Gram-posi-
tive bacteraemia and pneumonia in HIV-infected 
hospitalized patients, and its incidence in AIDS pa-
tients appears to be on the rise, with many studies 
demonstrating an annual increase in cases (9).
Bacterial bloodstream infections constitute a sig-
nificant public-health problem and present an im-
portant cause of morbidity and mortality in HIV-
infected patients. A survey among HIV-I patients in 
Malawi showed that 30% had bloodstream infec-
tions. Organisms isolated were mainly S. pneumoni-
ae (33%) and Mycobacterium tuberculosis (28%) (10). 
In a retrospective three-year study of all episodes of 
bloodstream infections in HIV-infected patients in 
Italy by Bonaldio et al. (11), the most frequent iso-
lates were coagulase-negative staphylococci (n=33), 
S. aureus (n=7), Pseudomonas sp. (n=7), non-typhoid 
Salmonella (n=4), and fungi (n=1). Most patients 
had a CD4 count of <100. 
To the best of our knowledge, there has been no 
previous study on bacterial bloodstream infections 
of teeming HIV-infected patients that abound in 
this country, apart from the limited survey car-
ried out by Ogunsola et al. (12). The present study 
was conducted to determine the status of bacterial 
bloodstream infections in HIV-infected patients in 
this environment in relation to their CD4 T lym-
phocyte counts. This information will assist in 
identifying clinical predictors of bloodstream infec-
tions and in planning appropriate therapy.
MATERIALS AND METHODS
Study subjects
Patients were consecutive attendants at the HIV 
clinic of the Lagos University Teaching Hospital 
(LUTH). The LUTH is a tertiary-level teaching hos-
pital and referral centre located in Lagos attending 
HIV-infected patients and others. The study was 
conducted during October 2005–September 2006.
The cohort consists of HIV-infected individuals 
referred to or identified at this hospital. The HIV- 
infected individuals included 86 males and 115 
females aged 14-65 years. The entire subjects were 
attending the outpatient department of the HIV 
clinic. 
The study was approved by the Medical Research 
and Ethics Committee of the Lagos University 
Teaching Hospital. Some patients were already on 
ART before the study commenced.
Serological diagnosis of HIV
Serum samples obtained from the 201 patients 
were screened for HIV antibodies by enzyme-linked 
immunosorbent assay (ELISA) using Murex 1+2 
kits (Murex Diagnostic, Dartfold, England). All sera 
found positive by ELISA were confirmed by West-
ern blot (13).
Determination of CD4 
CD4 was estimated by micromagnetic bead meth-
od using kits supplied by Dynal Beads, UK. The 
procedure involved the addition of micromag-
netic bead coated with anti-CD14 antibodies to 
whole blood. These magnetic beads bind to hu-
man monocytes that express anti-CD14 antigens. 
This is important so that these monocytes which 
equally express CD4 molecules are removed from 
the whole blood before quantitation of CD4+ cells. 
Following the depletion of blood monocytes, the 
second micromagnetic bead coated with anti-CD4 
was added to the monocyte-depleted blood. The 
blood was placed in the magnetic field so that all 
the CD4 bearing cells in 100 µL of blood were at-
tracted and isolated. These cells were resuspended 
in 100 µL of 5% glacial acetic acid tinted with Gen-
tian violet and counted under the light microscope 
using Neubauer counting chamber.
Collection and processing of blood samples 
Venous blood samples (20 mL) were taken from each 
patient, and 10 mL were aseptically inoculated into 
a pair of Oxoid Signal blood culture bottles system 
asceptically. The blood samples were subsequently 
incubated for 2-14 days according to the standards 
of the World Health Organization (WHO) (14). 
Thereafter, 0.1 mL of the sample was drawn using a 
sterile syringe and plated out on MacConkey, blood 
and chocolate agar plates using the streak plate 
technique. Duplicate plates were inoculated for 
each of the sample. The plates were then incubated 
at 37 0C for 18-24 hours and observed for bacterial 
growth. The chocolate agar plates were incubated 
under anaerobic conditions in an anaerobic jar for 
the possible isolation of microaerophiles.
Characterization and identification of 
bacterial isolates
Colonies appearing on the agar plates were subcul-
tured for purity, and a minimum of three colonies Adeyemi AI et al. Bacterial bloodstream infections in HIV-infected patients
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with identical morphology was selected individu-
ally and subjected to identification by standard 
biochemical tests (15). Finally, the isolates were 
confirmed using the API 20E and API staph-kits 
and were later identified using the API 20E (version 
4.0), API20 WE (version 6.0), and API STAPH (ver-
sion 4.0) software. Organisms identified as Staphy-
lococcus were further subjected to coagulase test.
Testing of antimicrobial sensitivity 
Antimicrobial sensitivity test was carried out on 
each isolate using Oxoid single antibiotics discs, fol-
lowing the recommended standards of the National 
Committee on Clinical Laboratory Standards (16); 
0.5 Macfarland standard of the pure culture of each 
isolate was inoculated into tryptose soya broth. Us-
ing sterile swab sticks, the resulting solution of each 
isolate was spread over plates of Mueller-Hinton 
agar until the surface became sticky. Coagulase-ne-
gative Staphylococci were screened for susceptibility 
to the following 17 antibiotics: ceftazidime (30 µg), 
cefotaxime (30 µg), ampicillin (10 µg), augmentin 
(30 µg), cefuroxime (30 µg), tetracycline (30 µg),     
chloramphenicol (30 µg), ofloxacillin (5 µg), pip- 
eracillin-tazobactam (P-100 µg, TZ-10 µg), penicil-
lin (10 unit), oxacillin (1 µg), vancomycin (30 µg), 
septrin (25 µg), amikacin (30 µg), cloxacillin (5 µg), 
erythromycin (5 µg), and gentamicin (10 µg). The 
Gram-negative rods were screened for susceptibili- 
ty to 12 of the listed drugs and nalidixic acid (30 
µg). The appropriate antibiotic discs were placed on 
the lawn of bacterial isolates (4 discs per plate). The 
plates were incubated at 37  0C for 24 hours after 
which the zones of inhibition were measured in 
mm using a table ruler. The results were recorded as 
susceptible, intermediate, or resistant. E. coli (NTCC 
10148) and S. aureus (ATTCC 12600) were used as 
control.
RESULTS
Distribution of age
The study population comprised 201 HIV patients 
—86 males and 115 females. They were aged 14-
65 years with a mean age of 34.3 [standard devia-
tion (SD) 9.9] years (Table 1). Of them, 143 (71.5%) 
were aged 20-40 years. Teenagers and people in the 
fifth decade seemed to share identical affliction rate 
(6%) while those in their fourth decade were more 
frequently affected (17.5%). The figure shows the 
number of study patients when they were first di-
agnosed HIV-positive.  
CD4 range, sex, and antiretroviral status
Table 2 shows the CD4 count range, antiretroviral 
therapy, and bloodstream infections of 140 of the 
201 patients. Ninety-four (67.1%) patients had a CD4 
Table 1. Age and sex distribution of 201 HIV/
AIDS patients studied
Age-
group
(years)
Male
(n=86)
Female
(n=115)
Total
(n=201)
Total 
%
11-20 2 10 12 6.0
21-30 26 44 70 34.8
31-40 33 40 73 36.3
41-50 18 15 33 16.4
51-60 6 6 12 6.0
>60 1 - 1 0.5
count of <200 cells/µL of blood. Seventeen (65%) 
of 26 patients positive for bloodstream infections 
belonged to this group. The majority (69.6%) of the 
patients with CD4 counts above the 200 cells/µL 
threshold were on antiretroviral therapy. All the 
patients but one who recorded >500 cells/µL were 
female.
Bacterial isolates
Twenty-six bacterial isolates comprising mainly 
15 coagulase-negative staphylococci (58%) and six 
non-typhoidal Salmonellae (23%) were isolated 
from the blood samples of 26 (12.9%) of the 201 
patients (Table 3). There was an unusual isola-
tion of Ochrobactrum anthropi (n=1), Moraxella 
sp. (n=1), and Chryseobacterium meningospecticum 
(n=1) from three patients. Other isolates were E. 
coli (n=1) and P. aeruginosa (n=1). Altogether, 26 
patients—17 females and nine males—had blood-
stream bacterial infections.
Antimicrobial susceptibility patterns
Table 4 shows the antimicrobial susceptibility pat-
terns of the staphylococci isolates to 17 antimicro-
bial agents while Table 5 shows those of the Gram-
negative rods to 13 drugs. The coagulase-negative 
staphylococci demonstrated good susceptibility 
patterns to oxacillin and vancomycin. The Gram-
negative  rods  also  demonstrated  good  sensitivi- 
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Table 2. CD4 count range, ART and BSI status of 140* HIV-positive patients attending Lagos University 
Teaching Hospital
CD4 range (cells/
uL of blood)
Male Female Total %
No. on 
ART (%)
No. not 
on ART (%)
No. positive 
for BSI (%)
<20 9 8 17 12.1     0 (0) 17 (25.0)   6 (23.1)
21-100 22 20 42 30.0 19 (26.3) 23 (33.8)   7 (26.9)
101-200 22 13 35 25.0 21 (29.2) 14 (20.6)   4 (15.4)
201-500 16 19 35 25.0 24 (33.3) 11 (16.2)   8 (30.8)
501-1,000 1 8 9 6.4   6 (8.3) 3 (4.4)  1 (3.8)
>1,000 - 2 2 1.4   2 (2.8) 0 (0)  0 (0)
Total 70 70 140 100.0 72 (100) 68 (100)  26 (100)
*61 patients have not done their CD4 count at the time of recruitment into the study; ART=Antiretroviral 
therapy; BSI=Bloodstream infection; HIV=Human immunodeficiency virus
ty patterns to ceftazidime, cefotaxime, augmentin, 
cefuroxime, and other antibiotics. Most staphylo-
cocci isolates were, however, resistant to ampicil-
lin (n=11, 73.3%), tetracycline (n=8, 53%), and 
penicillin G (n=11, 73.3%). The resistance pattern 
varied from single (TET or P) to sextiple (AMP-TET-
CM-OFX-P-CN) observed in one S. epidermidis iso-
late. The Gram-negative rods, on the other hand, 
were resistant to ampicillin (n=7, 63%), tetracycline 
(n=7, 63%), chloramphenicol (n=7, 63%), and sep-
trin (63%). They showed a pattern varying from 
single (TET or CAZ) to sextiple (AMP-AMC-TET-
Table 3. CD4 counts, antiretroviral treatment status, and bacteria isolated from 26 HIV-positive patients 
attending Lagos University Teaching Hospital
Sl. 
no.
Bacterial isolate
CD4 count 
cells/µL
of blood
ART status
Sex of 
patients
1 Staphylococcus scuri  224 + F
2 Staphylococcus cohni urealiticum 221 + F
3 Staphylococcus epidermidis 191 + M
4 Salmonella Typhimurium 55 - M
5 Staphylococcus warneri 145 + F
6 Staphylococcus epidermidis  288 + M
7 Staphylococcus epidermidis  34 - M
8 Staphylococcus xylosus 62 - F
9 Staphylococcus chromogenes 10 - F
10 Staphylococcus cohni cohni 18 - F
11 Staphylococcus epidermidis 460 + F
12 Salmonella Enteritidis  15 - F
13 Salmonella Enteritidis  146 - M
14 Staphylococcus cohni urealiticum 60 - F
15 Staphylococcus epidermidis 6 - F
16 Staphylococcus epidermidis 604 + F
17 Staphylococcus  warneri 46 - M
18 Salmonella Typhimurium 392 + F
19 Salmonella Typhimurium 14 - M
20 Staphylococcus  epidermidis 7 - M
21 Salmonella Typhimurium 47 - M
22 Escherichia coli 360 + F
23 Pseudomonas flourescence  228 + F
24 Ochrobactrum anthropi 220 + F
25 Moraxella sp. 110 - F
26 Chryseobacterium meningospecticum 88 - M
ART=Antiretroviral therapy; F=Female; HIV=Human immunodeficiency virus; M=Male Adeyemi AI et al. Bacterial bloodstream infections in HIV-infected patients
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CM-OFX-SXT). The latter was encountered in the 
E. coli isolate. 
DISCUSSION
The age range of 14-65 years with a mean of 34 
years of HIV patients attending the LUTH was ob-
served to be in line with the general picture of HIV/
AIDS infection worldwide, especially in Africa. It 
has been noted that the pandemic affects mainly 
sexually-active age-groups (3,17). There were more 
females than males in the study subjects (115:86), 
and this is a reflection of disproportionate impact 
of HIV on women and girls than on men. Obi et 
al. established that there were more HIV-positive 
females than males in studies in South Africa, in-
dicating a ‘gender bias’ (18). The vulnerability of 
women to HIV in sub-Saharan Africa stem from 
their greater physiological susceptibility and the se-
vere social, legal and economic disadvantages that 
confront them (19). Our study also confirmed the 
upsurge in reported cases of HIV infection in Ni-
geria until 2005 when a noticeable decline in infec-
tion rate began (2). It was observed in this study 
that the majority (67%) of the patients had CD4 
counts of <200 cells/µL of blood, and this was more 
pronounced among subjects who were not yet on 
antiretroviral therapy. Among the later group were 
five subjects whose CD4 counts were <10 cells/
µL. This observation is in agreement with already- 
established knowledge of HIV pathogenesis which 
indicates that there is a steady decline in the CD4 
counts of patients and by the time opportunistic 
infections set in there may be no more CD4 cells 
present in the immune system (5). The findings of 
our study also showed that 48.5% of the subjects 
had no access to antiretroviral treatment. Some of 
them had been diagnosed HIV-positive as far back 
as 2000 and 2001 respectively. This lack of access to 
medical care, especially the much-needed antiret-
roviral drugs in Africa, has been widely reported by 
the WHO and other workers (17). Although this 
problem is now being addressed in Nigeria at the 
governmental level, it will take some time before 
every patient in need will be able to access antiret-
roviral therapy. Another disturbing fact is that some 
patients who have been on antiretroviral therapy 
for a fairly long time had low CD4 counts. This 
could be attributed to non-adherence to treatment 
regime and also lack of proper dietary balance. It 
is known that the many subjects belonged to the 
low-income group (itenary traders and artisans) 
and probably could afford the cost of the drugs and 
nourishable foods which are important ingredients 
for boosting the population of T cells in their blood. 
However, the majority of the patients on antiretro-
viral therapy had their (CD4) counts above the 200 
cells/µL threshold, and nearly all the patients who 
recorded >500 cells/µL were female.Adeyemi AI et al. Bacterial bloodstream infections in HIV-infected patients
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Bloodstream infections have long been observed to 
appear frequently in HIV/AIDS patients. Bekele 
et al. reported that, of 1,225 hospitalized patients 
at the University of Florida Health Science Center, 
88 (7%) had bloodstream infections, and 73 of 
the infections were community-acquired (20). 
Comparatively, same workers recorded a bacterial 
infection rate of 12% in patients with HIV when 
blood of 201 patients were cultured. Ogunsola et 
al. reported the infection rate of 33% in 67 AIDS 
patients attending the LUTH (12). In the present 
study, a prevalence of 12.9% was recorded. In 
2000, Ippolito et al. also recorded 12.1% cases of 
bloodstream infections in a prospective multicen-
tre study in HIV patients with advanced stage of 
the disease (21). Similarly, 30% prevalence rate 
of bloodstream infections was recorded in Ma-
lawian patients (10).
Bloodstream infections constitute a significant 
public-health problem and represent an important 
cause of morbidity and mortality in HIV/AIDS pa-
tients. In our study, coagulase-negative Gram sta-
phylococci dominated the number of bacteria iso-
lated as 15 (57.7%) of the 26 isolates belonged to 
this group. Gooze and Choi et al. had established 
that coagulase-negative staphylococci are a major 
cause of infection in immuno-compromised pa-
tients (22,23). Similarly, Bonadio et al. reported that 
the most frequently-isolated bacteria were coagu-
lase-negative staphylococci (11), and Staphylococcus 
cohnii had been implicated in community-acquired 
pneumonia in an HIV-infected patient (24). Other 
organisms encountered in our study included non-
typhoid Salmonellae (n=6), P. fluorescens (n=1), and 
E. coli (n=1). Bonadio et al. also established the 
presence of non-typhoid Salmonellae, Pseudomonas 
sp., and one fungus in 68 blood samples from HIV-
infected patients with bloodstream infections (11). 
An increase in the frequency and severity of non- 
typhoid Salmonella has been reported with AIDS, 
and infections often present as recurrent diarrhoea 
with relapsing bacteraemia (11,12,25). S. Typhimu-
rium and S. Enteritidis are the two most common 
serotypes isolated from blood of patients with AIDS 
in the United States (26) and Africa (7,27). This is in 
agreement with the findings of our study. Invasive 
non-typhoid Salmonellae are endemic in sub-Saha-
ra Africa, and it has been postulated that transmis-
sion between humans—both within and outside 
health facilities (community-acquired)—may be 
important (28). P. aerugnosa and other Pseudomonas 
have also been more frequently recognized as no-
socomial bacteraemia in HIV-infected patients (29) 
and were reported to account for 12% in hospital 
patients in Italy (30). Only one of the blood sam- 
ples cultured grew E. coli. This organism is not fre- 
quently isolated in cases of bloodsteam infections 
among HIV/AIDS patients, and of 861 blood sam-
ples examined by Ippolito et al. (21), only seven 
were positive for E. coli. An unusual occurrence was 
the isolation of O. anthropi, C. meningosepticum, 
and Moraxella sp. Early reports on bloodstream in-
fections had documented the prevalence of encap-
sulated bacteria and non-typhoid Salmonellae but, 
during the recent years, broader aetiological spec-
trum has become evident. The first two cases of 
O. anthropi-associated septicaemia occurring in pa-
tient with HIV-infected disease were reported about 
a decade ago (31). Similarly, although the role of C. 
meningosepticum in immunocompromised host has 
been recognized (32), clinical data detailing this 
infection remain limited. Hung et al. reported that 
the presence of central venous line infection was 
associated with a poor outcome in patients with C. 
meningosepticum (33). According to Manfredi et al., 
M. catarrhalis may be responsible for appreciable 
morbidity among patients with advanced HIV in-
fections with low CD4 counts (34).
Results of antimicrobial susceptibility tests revealed 
that most coagulase-negative staphylococci were 
susceptible to most antibiotics screened. Specifi-
cally, none was resistant to methicillin and vanco-
mycin. Some of them were resistant to ampicillin, 
tetracycline, and penicillin. This is in line with re-
sults of previous studies. Shittu et al. reported that 
all 200 isolates of S. aureus from clinical samples 
were susceptible to teicoplanin, vancomycin, fusid-
ic acid, and rifampicin but showed high resistance 
to penicillin, sulphonamides, and tetracycline (35). 
Taiwo et al. also reported cumulative resistance of 
38-85% to chloramphenicol, tetracycline, ampicil-
lin, gentamycin, and penicillin G among bacterial 
isolates from bloodstream infections in a Nigerian 
university teaching hospital (36). The isolated 
Gram-negative bacteria also showed good sensitivi-
ty patterns to ceftazidin, cefotaxime, augmentin, 
and cefuroxime, indicating that they do not pro-
duce extended betalactamase. However, they too 
showed varying resistance to older-generation an-
tibiotics, such as ampicillin, tetracycline, chloram-
phenicol, and septrin. The multi-drug resistance 
patterns observed in this study are similar to those 
earlier reported by Adeleye and Adesoye (37) where 
septiple resistance comprising SXT-CT-FD-S-C-TET-
AM was found to dominate in clinical isolates stud-
ied. Similarly, Taiwo et al. observed seven patterns 
of antibiotic resistance, with resistance comprsing 
the earlier-mentioned antibiotics (AMP-TET-C-
GM-P) being most common in bloodstream bac-
terial isolates (36).Adeyemi AI et al. Bacterial bloodstream infections in HIV-infected patients
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The present study, thus, established that bacterial 
bloodstream infection is a common occurrence   
in HIV-positive patients attending the LUTH. 
The prevalence is comparable with what was ob-
tained in the developed world but less than what 
is observed in the South African region. The ma-
jority of the study patients with bloodstream infec-
tion had low CD4 counts, and the antibiotic resist-
ance profile of the bacteria indicate that these are 
community-acquired. Therefore, a continuous 
surveillance and intervention strategies should be 
put in place to manage cases of bloodstream infec-
tions in HIV-positive patients in Nigeria. 
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